Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
ANIP
OMCL
Add up to 3 more stocks
ANIP
ANI Pharmaceuticals, Inc.
-1.46%
$71.52-1.06Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.63B
52W Range
$69.58 - $97.00
OMCL
Omnicell, Inc.
+2.37%
$35.46+0.82Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.61B
52W Range
$29.06 - $55.00
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 15.45 | 41.97 |
| Forward P/E | 7.71 | 15.63 |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 2.72 | 1.25 |
| P/S Ratio | 1.66 | 1.29 |
| P/FCF Ratio | N/A | 11.41 |
| EV/EBITDA | 6.76 | 10.75 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 51.0% | 44.8% |
| Operating Margin | 15.3% | 4.7% |
| Net Margin | 10.8% | 3.1% |
| ROE | 17.7% | 3.0% |
| ROA | 7.1% | 2.0% |
| ROIC | 9.3% | 2.4% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.91 | 1.64 |
| Quick Ratio | 2.41 | 1.43 |
| Debt/Equity | 0.55 | 0.15 |
| Interest Coverage | 4.05 | 2.98 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.